Twenty two percent of patients had positive p53 antibodies which were associated with higher clinical stage, lymph node metastases, negative ER expression and positive c-erbB-2 (Her-2) status [19]. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.